Patient awareness campaigns and digital health platforms are increasing treatment-seeking behavior among urban populations with obesity concerns
Pill forms of the drugs simplify the entire process from manufacturing to administration, says Sean Wharton, an obesity medicine clinician and researcher at the Wharton Medical Clinic in Ontario
In the study, researchers at Washington University School of Medicine in St
Studies have also shown the potential of the DPP-4 inhibitor alogliptin in increasing production of brain-derived neurotrophic factor (BDNF), leading to decrease toxic release of glutamate [67]
It is important to note that patients with a history of major depression were actually excluded from the phase 3 randomized controlled trials (RCTs) of these medications 10,11,12,13,14,15,21,22,23
Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, et al